Increasing evidence for small airway role in asthma intensity

November 20, 2012
Increasing evidence for small airway role in asthma intensity
There is increasing evidence that the small airways contribute significantly to the clinical expression and severity of asthma, according to research published online Nov. 9 in Allergy.

(HealthDay)—There is increasing evidence that the small airways contribute significantly to the clinical expression and severity of asthma, according to research published online Nov. 9 in Allergy.

Maarten van den Berge, M.D., Ph.D., from the University of Groningen in the Netherlands, and colleagues reviewed the clinical relevance of small airway disease and its implications for the treatment of asthma.

The researchers found that, based on increasing evidence, small airway disease was shown to be associated with symptoms, , and bronchial hyper-responsiveness. When developing inhaled treatments for small airway disease, and distribution are of key importance. A higher drug deposition into the peripheral lung has been enabled by the availability of hydrofluoroalkane-134a (HFA)-ciclesonide, HFA-beclomethasone dipropionate, and other small-particle aerosols. These small-particle potentially provide additional clinical benefits versus large-particle treatment. Since conventional spirometry mainly reflects large , improved methods are needed to assess small airway disease and its response to treatment.

"Overall, the emerging evidence from recent years suggests an important role of the small airways in asthma because they contribute to the clinical expression of the disease and responsiveness to treatment with small- or large-particle inhaled drugs," the authors write. "More research is now urgently needed to answer the many remaining questions which currently impact the treatment for asthma and obstructive airway diseases in general."

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Research revelation could shape future long-term treatment of asthma

More information: Abstract
Full Text

Related Stories

Obese asthma patients have reduced treatment response

June 25, 2012

(HealthDay) -- Compared with lean patients, obese patients with asthma have higher neutrophil counts and a reduced response to corticosteroid treatment, according to a study published online June 12 in Allergy.

Recommended for you

How antibodies access neurons to fight infection

May 18, 2016

Yale scientists have solved a puzzle of the immune system—how antibodies enter the nervous system to control viral infections. Their finding may have implications for the prevention and treatment of a range of conditions, ...

New study suggests rethink of dementia causes

May 12, 2016

University of Adelaide researchers have developed a new theory for the causes of dementia and other neurodegenerative diseases, involving an out-of-control immune system.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.